Unknown Primary Site, Cancer of, Childh... Clinical Trials

• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
  ClinicalTrials.gov Identifier: NCT00022178 - Active, not recruiting
  squamous cell carcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; undifferentiated carcinoma of unknown primary; ...
  
• Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193622 - Active, not recruiting
  Neoplasms, Unknown Primary
  
• Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00003558 - Active, not recruiting
  adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary
  
• Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00066781 - Active, not recruiting
  adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; squamous cell carcinoma of unknown primary; ...
  
• Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00004005 - Active, not recruiting
  adult solid tumor; carcinoma of unknown primary; childhood solid tumor; Colon Cancer; Rectal Cancer
  
• Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients with Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00148135 - Recruiting
  Carcinoma of Unknown Primary Site (CUP)
  
• Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00360360 - Recruiting
  Neoplasm, Unknown Primary
  
• Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193609 - Recruiting
  Neoplasms, Unknown Primary
  
• Gemcitabine, Docetaxel, and Capecitabine in Treating Patients with Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00119314 - Active, not recruiting
  newly diagnosed carcinoma of unknown primary; recurrent carcinoma of unknown primary
  
• Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00003526 - Recruiting
  adenocarcinoma of unknown primary; recurrent carcinoma of unknown primary
  
• Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193596 - Recruiting
  Neoplasms, Unknown Primary
  
• Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00357630 - Active, not recruiting
  Carcinoma of Unknown Primary; Pain
  
• Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
  ClinicalTrials.gov Identifier: NCT00047125 - Active, not recruiting
  newly diagnosed carcinoma of unknown primary; squamous cell carcinoma of unknown primary
  
• Gemox as First and Second Line Therapy in Unknown Primary Cancer
  ClinicalTrials.gov Identifier: NCT00353145 - Active, not recruiting
  Unknown Primary Neoplasms
  
• Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00004136 - Active, not recruiting
  recurrent adult primary liver cancer; stage III childhood liver cancer; liver metastases; advanced adult primary liver cancer; ...
  
• Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003530 - Active, not recruiting
  stage IV childhood liver cancer; recurrent childhood liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.
  ClinicalTrials.gov Identifier: NCT00003943 - Active, not recruiting
  extensive stage small cell lung cancer; newly diagnosed carcinoma of unknown primary
  
• PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors
  ClinicalTrials.gov Identifier: NCT00269373 - Recruiting
  Unknown Primary Tumor
  
• Randomized Fase II Study: Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor
  ClinicalTrials.gov Identifier: NCT00458315 - Not yet recruiting
  Unknown Primary Tumors
  
• The Final Diagnosis and Treatment Result of Metastatic Cervical Carcinoma of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00302588 - Recruiting
  Metastasis Cervical Lymph Nodes of Unknown Primary Carcinoma
  
• Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00201734 - Recruiting
  Tumors; Unknown Primary Tumors; Adenocarcinoma
  
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00012181 - Active, not recruiting
  childhood bone cancer; childhood brain cancer; childhood eye cancer; childhood kidney tumors; childhood non-Hodgkin's lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003758 - Active, not recruiting
  acute leukemia; childhood cancer; hematopoietic/lymphoid cancer; Cancer; Leukemia; cellular diagnosis, childhood acute myeloid leukemia; ...
  
• Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
  ClinicalTrials.gov Identifier: NCT00003907 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003994 - Active, not recruiting
  stage I childhood liver cancer; recurrent childhood liver cancer; childhood hepatoblastoma
  
• DX-8951f in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00004108 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00040898 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00098761 - Active, not recruiting
  childhood brain tumor; childhood meningioma
  
• Cilengitide in Treating Children With Refractory Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00063973 - Active, not recruiting
  childhood brain tumor; childhood meningioma; childhood spinal cord tumors
  
• Chemotherapy in Treating Children With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003912 - Active, not recruiting
  childhood hepatoblastoma; childhood hepatocellular carcinoma; childhood liver cancer
  
• Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00083226 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00005629 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00022334 - Active, not recruiting
  localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
  
• Oxaliplatin in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00052364 - Active, not recruiting
  advanced adult primary liver cancer; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003476 - Recruiting
  childhood brain tumor; childhood meningioma
  
• Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00006010 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy
  ClinicalTrials.gov Identifier: NCT00530283 - Recruiting
  Squamous Cell Cancer
  
• Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109954 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003714 - Active, not recruiting
  advanced adult primary liver cancer; liver metastases; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00077142 - Active, not recruiting
  advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00077441 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00004922 - Completed
  newly diagnosed carcinoma of unknown primary; Neuroendocrine Carcinoma; recurrent carcinoma of unknown primary; stage III Merkel cell carcinoma; ...
  
• AZD2171 in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00238394 - Active, not recruiting
  Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer
  
• Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00071994 - Active, not recruiting
  advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00020774 - Active, not recruiting
  recurrent adult primary liver cancer; localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00047229 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00041275 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00055692 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized unresectable adult primary liver cancer
  
• Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00009893 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; ...
  
• Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma Cancer
  ClinicalTrials.gov Identifier: NCT00057980 - Active, not recruiting
  advanced adult primary liver cancer; localized unresectable adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00004248 - Active, not recruiting
  recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Tamoxifen in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003424 - Active, not recruiting
  advanced adult primary liver cancer; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer; Quality of Life
  
• Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00003296 - Active, not recruiting
  recurrent adult primary liver cancer; localized gallbladder cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer
  ClinicalTrials.gov Identifier: NCT00579293 - Active, not recruiting
  Childhood Cancer
  
• T900607 in Treating Patients With Unresectable Liver Cancer
  ClinicalTrials.gov Identifier: NCT00054262 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Doxorubicin With or Without Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00079027 - Active, not recruiting
  advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Tipifarnib in Preventing Cancer in Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00029354 - Recruiting
  childhood neurofibrosarcoma; childhood soft tissue sarcoma
  
• Hepatic Arterial Infusion Plus Internal Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00039078 - Recruiting
  localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Gene Therapy in Treating Patients With Cancer of The Liver
  ClinicalTrials.gov Identifier: NCT00003147 - Active, not recruiting
  adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue
  ClinicalTrials.gov Identifier: NCT00581698 - Active, not recruiting
  Melanoma
  
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00007813 - Active, not recruiting
  childhood liver cancer; Bone Cancer; Testicular Cancer; Brain Tumor
  
• Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
  ClinicalTrials.gov Identifier: NCT00027768 - Active, not recruiting
  localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00006379 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
  ClinicalTrials.gov Identifier: NCT00081094 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized resectable adult primary liver cancer
  
• Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
  ClinicalTrials.gov Identifier: NCT00025441 - Active, not recruiting
  childhood rhabdomyosarcoma; childhood soft tissue sarcoma; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma
  
• O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
  ClinicalTrials.gov Identifier: NCT00003765 - Active, not recruiting
  recurrent childhood brain stem glioma; childhood choroid plexus tumor; recurrent childhood visual pathway glioma; ...
  
• Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00128596 - Recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer
  
• Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00126477 - Active, not recruiting
  childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; Leukemia; Quality of Life
  
• Docetaxel in Treating Children With Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002825 - Active, not recruiting
  recurrent childhood brain stem glioma; recurrent childhood rhabdomyosarcoma; recurrent neuroblastoma; recurrent childhood ependymoma; ...
  
• Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
  ClinicalTrials.gov Identifier: NCT00049322 - Recruiting
  localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
  
• 506U78 in Treating Patients With Refractory Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00002970 - Active, not recruiting
  recurrent childhood lymphoblastic lymphoma; T-cell childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
  
• Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00003557 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00532285 - Active, not recruiting
  Breast Cancer; Primary
  
• Phase II Study of Modified Triple Doublet Therapy in Women with Newly Diagnosed Mullerian Carcinoma
  ClinicalTrials.gov Identifier: NCT00157560 - Active, not recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
  
• Donor Bone Marrow Transplant in Treating Young Patients with Cancer Or a Non-Cancerous Disease
  ClinicalTrials.gov Identifier: NCT00118326 - Active, not recruiting
  Wilms'' tumor and other childhood kidney tumors; childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; childhood rhabdomyosarcoma; Leukemia; ...
  
• High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00002722 - Active, not recruiting
  childhood gastrointestinal cancer; stage III gastric cancer; stage IV gastric cancer
  
• Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
  ClinicalTrials.gov Identifier: NCT00132041 - Active, not recruiting
  adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00025363 - Active, not recruiting
  recurrent childhood rhabdomyosarcoma; embryonal childhood rhabdomyosarcoma; alveolar childhood rhabdomyosarcoma; ...
  
• Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
  ClinicalTrials.gov Identifier: NCT00002463 - Active, not recruiting
  untreated childhood cerebellar astrocytoma; low-grade childhood cerebral astrocytoma; ...
  
• Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
  ClinicalTrials.gov Identifier: NCT00019474 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; adult primary liver cancer
  
• Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00008164 - Active, not recruiting
  Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• ABT-751 in Treating Young Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00036959 - Active, not recruiting
  childhood cancer
  
• Genetic Study of Patients With von Hippel-Lindau Syndrome
  ClinicalTrials.gov Identifier: NCT00003866 - Active, not recruiting
  childhood kidney/urinary cancer; Renal Cell Cancer
  
• Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00030511 - Active, not recruiting
  localized resectable adult primary liver cancer; recurrent adult primary liver cancer; localized extrahepatic bile duct cancer; ...
  
• Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00059865 - Active, not recruiting
  advanced adult primary liver cancer; unresectable gallbladder cancer; unresectable extrahepatic bile duct cancer; ...
  
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00003427 - Active, not recruiting
  Pancreatic Cancer; Colon Cancer; Gastric Cancer; Rectal Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer
  
• Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00004056 - Active, not recruiting
  childhood acute megakaryocytic leukemia (M7); untreated childhood acute myeloid leukemia; ...
  
• Irinotecan and Capecitabine in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003867 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer; Colon Cancer; Rectal Cancer; Breast Cancer
  
• BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00023946 - Active, not recruiting
  adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
  
• Prospective Trial of Vaccine Responses in Childhood Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00505063 - Recruiting
  Childhood Cancer; Multiple Diseases
  
• Evaluating the Transferability of a Successful, Hospital-Based, Childhood Obesity Clinic to Primary Care: a Pilot Study
  ClinicalTrials.gov Identifier: NCT00536536 - Not yet recruiting
  Childhood Obesity
  
• Combination Chemotherapy in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003701 - Active, not recruiting
  stage III bladder cancer; childhood kidney/urinary cancer; transitional cell carcinoma of the bladder; ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00004010 - Active, not recruiting
  stage III childhood Hodgkin's disease; stage IV childhood Hodgkin's disease; childhood lymphocyte predominant Hodgkin's disease; ...
  
• Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002884 - Active, not recruiting
  childhood gastrointestinal cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
  
• Tariquidar Plus Chemotherapy in Treating Children With Relapsed or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00020514 - Active, not recruiting
  Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003926 - Active, not recruiting
  childhood soft tissue sarcoma; childhood liver cancer; adult soft tissue sarcoma; Bone Cancer; ovarian sarcoma; Testicular Cancer; Brain Tumor; ...
  
• Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
  ClinicalTrials.gov Identifier: NCT00107458 - Active, not recruiting
  childhood brain tumor; childhood meningioma; childhood solid tumor; childhood spinal cord tumors
  
• Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003001 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; childhood gastrointestinal cancer; stage IV colon cancer
  
• Chemotherapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003044 - Active, not recruiting
  localized unresectable adult primary liver cancer
  
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood
  ClinicalTrials.gov Identifier: NCT00030667 - Active, not recruiting
  Ewing's family of tumors; childhood soft tissue sarcoma; Gastrointestinal Cancer; metastatic cancer; Neuroblastoma; Osteosarcoma